Senate still hasn’t made hard decisions on lowering insulin costs

WASHINGTON — Senate Democrats are trying to cap insulin costs for every American, but they haven’t figured out the thorniest issue: exactly how to do it.

As a health care package begins to take shape in the Senate, key lawmakers are scrambling to ensure their competing versions of insulin affordability legislation are included. There are two leading proposals that include different versions of what a $35 cap on insulin could look like.

Senate Majority Leader Chuck Schumer is going to have to mediate, and he hasn’t made any commitments yet.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Already have an account? Log in

Individual plans

Group plans

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe

Log In